Biological agents in rheumatology: advantages, limitations, and safety profile of molecularly targeted therapy. OJMNS [Internet]. 2026 Feb. 26 [cited 2026 May 19];3(2):174-80. Available from: https://innoworld.net/index.php/ojmns/article/view/1951